NeoGenomics, Inc. Cost of Revenue
NeoGenomics, Inc. (NEO) reported Cost of Revenue of $109.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-28
- NeoGenomics, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $109.78M, a 5.48% increase year-over-year.
- NeoGenomics, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $105.81M, a 11.62% increase year-over-year.
- NeoGenomics, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $106.83M, a 12.75% increase year-over-year.
- NeoGenomics, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $107.35M, a 15.50% increase year-over-year.
- NeoGenomics, Inc. cost of goods and services sold for fiscal 2025 was $413.04M, a 11.49% increase from fiscal 2024.
- NeoGenomics, Inc. cost of goods and services sold for fiscal 2024 was $370.47M, a 6.75% increase from fiscal 2023.
- NeoGenomics, Inc. cost of goods and services sold for fiscal 2023 was $347.04M, a 7.83% increase from fiscal 2022.
- NeoGenomics, Inc. cost of goods and services sold for fiscal 2022 was $321.83M, a 8.26% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $109.78M 10-Q · filed 2026-07-28 | $215.59M 10-Q · filed 2026-07-28 | $322.41M derived: sum of 3 quarters · filed 2026-07-28 | $429.76M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | $105.81M 10-Q · filed 2026-04-28 | $212.63M derived: sum of 2 quarters · filed 2026-04-28 | $319.99M derived: sum of 3 quarters · filed 2026-04-28 | $424.06M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $106.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $214.18M derived: sum of 2 quarters · filed 2026-02-17 | $318.25M derived: sum of 3 quarters · filed 2026-07-28 | $413.04M 10-K · filed 2026-02-17 |
| 2025-09-30 | $107.35M 10-Q · filed 2025-10-28 | $211.42M derived: sum of 2 quarters · filed 2026-07-28 | $306.21M 10-Q · filed 2025-10-28 | $400.95M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $104.07M 10-Q · filed 2026-07-28 | $198.86M 10-Q · filed 2026-07-28 | $293.60M derived: sum of 3 quarters · filed 2026-07-28 | $386.55M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $94.79M 10-Q · filed 2026-04-28 | $189.53M derived: sum of 2 quarters · filed 2026-04-28 | $282.48M derived: sum of 3 quarters · filed 2026-04-28 | $374.48M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $94.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $187.69M derived: sum of 2 quarters · filed 2026-02-17 | $279.69M derived: sum of 3 quarters · filed 2026-02-17 | $370.47M 10-K · filed 2026-02-17 |
| 2024-09-30 | $92.94M 10-Q · filed 2025-10-28 | $184.95M derived: sum of 2 quarters · filed 2025-10-28 | $275.72M 10-Q · filed 2025-10-28 | $363.69M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $92.01M 10-Q · filed 2025-07-29 | $182.78M 10-Q · filed 2025-07-29 | $270.74M derived: sum of 3 quarters · filed 2026-02-17 | $360.39M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $90.77M 10-Q · filed 2025-04-29 | $178.74M derived: sum of 2 quarters · filed 2026-02-17 | $268.38M derived: sum of 3 quarters · filed 2026-02-17 | $355.40M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $87.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $177.61M derived: sum of 2 quarters · filed 2026-02-17 | $264.63M derived: sum of 3 quarters · filed 2026-02-17 | $347.04M 10-K · filed 2026-02-17 |
| 2023-09-30 | $89.64M 10-Q · filed 2024-11-05 | $176.67M derived: sum of 2 quarters · filed 2024-11-05 | $259.07M 10-Q · filed 2024-11-05 | $340.95M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $87.03M 10-Q · filed 2024-07-30 | $169.43M 10-Q · filed 2024-07-30 | $251.31M derived: sum of 3 quarters · filed 2025-02-18 | $331.20M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $82.41M 10-Q · filed 2024-04-30 | $164.29M derived: sum of 2 quarters · filed 2025-02-18 | $244.18M derived: sum of 3 quarters · filed 2025-02-18 | $325.30M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $81.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $161.77M derived: sum of 2 quarters · filed 2025-02-18 | $242.90M derived: sum of 3 quarters · filed 2025-02-18 | $321.83M 10-K · filed 2025-02-18 |
| 2022-09-30 | $79.89M 10-Q · filed 2023-11-06 | $161.01M derived: sum of 2 quarters · filed 2023-11-06 | $239.95M 10-Q · filed 2023-11-06 | $320.43M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $81.13M 10-Q · filed 2023-08-08 | $160.06M 10-Q · filed 2023-08-08 | $240.54M derived: sum of 3 quarters · filed 2024-02-20 | $314.64M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $78.94M 10-Q · filed 2023-05-09 | $159.41M derived: sum of 2 quarters · filed 2024-02-20 | $233.51M derived: sum of 3 quarters · filed 2024-02-20 | $302.25M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $80.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $154.58M derived: sum of 2 quarters · filed 2024-02-20 | $223.31M derived: sum of 3 quarters · filed 2024-02-20 | $297.27M 10-K · filed 2024-02-20 |
| 2021-09-30 | $74.10M 10-Q · filed 2022-11-08 | $142.84M derived: sum of 2 quarters · filed 2022-11-08 | $216.79M 10-Q · filed 2022-11-08 | $285.34M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $68.73M 10-Q · filed 2022-08-09 | $142.69M 10-Q · filed 2022-08-09 | $211.24M derived: sum of 3 quarters · filed 2023-02-24 | $282.62M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $73.96M 10-Q · filed 2022-05-09 | $142.50M derived: sum of 2 quarters · filed 2023-02-24 | $213.88M derived: sum of 3 quarters · filed 2023-02-24 | $272.85M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $68.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $139.92M derived: sum of 2 quarters · filed 2023-02-24 | $198.89M derived: sum of 3 quarters · filed 2023-02-24 | $258.56M 10-K · filed 2023-02-24 |
| 2020-09-30 | $71.38M 10-Q · filed 2021-11-04 | $130.35M derived: sum of 2 quarters · filed 2021-11-04 | $190.01M 10-Q · filed 2021-11-04 | $246.96M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $58.97M 10-Q · filed 2021-08-09 | $118.63M 10-Q · filed 2021-08-09 | $175.58M derived: sum of 3 quarters · filed 2022-02-25 | $229.42M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $59.66M 10-Q · filed 2021-05-06 | $116.61M derived: sum of 2 quarters · filed 2022-02-25 | $170.45M derived: sum of 3 quarters · filed 2022-02-25 | $223.19M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $56.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $110.78M derived: sum of 2 quarters · filed 2022-02-25 | $163.53M derived: sum of 3 quarters · filed 2022-02-25 | $211.99M 10-K · filed 2022-02-25 |
| 2019-09-30 | $53.84M 10-Q · filed 2020-10-29 | $106.59M derived: sum of 2 quarters · filed 2020-10-29 | $155.05M 10-Q · filed 2020-10-29 | $194.41M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $52.75M 10-Q · filed 2020-07-31 | $101.21M 10-Q · filed 2020-07-31 | $140.57M derived: sum of 3 quarters · filed 2021-02-25 | $177.35M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $48.46M 10-Q · filed 2020-04-29 | $87.83M derived: sum of 2 quarters · filed 2021-02-25 | $124.60M derived: sum of 3 quarters · filed 2021-02-25 | $161.82M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $39.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $76.14M derived: sum of 2 quarters · filed 2021-02-25 | $113.36M derived: sum of 3 quarters · filed 2021-02-25 | $149.48M 10-K · filed 2021-02-25 |
| 2018-09-30 | $36.77M 10-Q · filed 2019-11-13 | $73.99M derived: sum of 2 quarters · filed 2019-11-13 | $110.11M 10-Q · filed 2019-11-13 | $144.77M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $37.22M 10-Q · filed 2019-08-07 | $73.34M 10-Q · filed 2019-08-07 | $108.00M derived: sum of 3 quarters · filed 2020-02-28 | $142.24M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $36.12M 10-Q · filed 2019-05-08 | $70.78M derived: sum of 2 quarters · filed 2020-02-28 | $105.02M derived: sum of 3 quarters · filed 2020-02-28 | |
| 2017-12-31 | $34.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $68.90M derived: sum of 2 quarters · filed 2020-02-28 | $138.29M 10-K · filed 2020-02-28 | |
| 2017-09-30 | $34.24M 10-Q · filed 2018-11-06 | $103.63M 10-Q · filed 2018-11-06 | ||
| 2016-12-31 | $133.70M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |